Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Open-market sale Chief Technology Officer sold 3,000 shares at $24.50 ($73,500)
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 10,200 shares at $23.94 ($244,188)
  7. 10-K Report Annual Report
  8. 8-K Event Material agreement · Results of operations
  9. 4 Open-market sale Chief Technology Officer sold 3,000 shares at $20.42 ($61,260)
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 4 Open-market sale Chief Financial Officer sold 6,895 shares at $21.39 ($147,484)
  20. 4 Derivatives Options or other derivatives

Page 23 of 37 · 731 filings